Microsomal N-glucuronidation of nicotine and cotinine: Human hepatic interindividual, human intertissue, and interspecies hepatic variation

Drug Metabolism and Disposition

Volumn 30, Issue 12, 2002, Pages 1478-1483

  Ghosheh, Omar ^a   Hawes, Edward M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; GLUCURONOSYLTRANSFERASE; NICOTINE; URIDINE DIPHOSPHATE GLUCURONIC ACID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG TRANSFORMATION; FEMALE; GASTROINTESTINAL TRACT; GENDER; HUMAN; HUMAN CELL; KIDNEY; LIVER MICROSOME; LUNG; MALE; MICROSOME; NONHUMAN; PRIORITY JOURNAL; SMOKING; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DOG; FISCHER 344 RAT; GENETIC VARIABILITY; GENETICS; GUINEA PIG; MACACA; METABOLISM; MINIPIG; MOUSE; RABBIT; RAT; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; COTININE; DOGS; FEMALE; GUINEA PIGS; HUMANS; MACACA FASCICULARIS; MALE; MICE; MICROSOMES, LIVER; NICOTINE; RABBITS; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SMOKING; SPECIES SPECIFICITY; SWINE, MINIATURE; URIDINE DIPHOSPHATE GLUCURONIC ACID; VARIATION (GENETICS);

EID: 0036893113     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.30.12.1478     Document Type: Article

References (38)

1. Benowitz NL and Jacob P III (2000) Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism. Clin Pharmacol Ther 67:653-659.
2. Benowitz NL, Jacob P III, Fong I, and Gupta S (1994) Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 268:296-303.
3. Benowitz NL, Perez-Stable EJ, Fong I, Modin G, Herrera B, and Jacob P 3rd (1999) Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther 291:1196-1203.
4. Byrd GD, Chang K-M, Greene JM, and deBethizy JD (1992) Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine and trans-3′-hydroxycotinine in smokers. Drug Metab Dispos 20:192-197.
5. Caldwell WS, Greene JM, Byrd GD, Chang KM, Uhrig MS, deBethizy JD, Crooks PA, Bhatti BS, and Riggs RM (1992) Characterization of the glucuronide conjugate of cotinine: A previously unidentified major metabolite of nicotine in smokers' urine. Chem Res Toxicol 5:280-285.
6. Chiu S-HL and Huskey S-EW (1998) Species differences in N-glucuronidation. Drug Metab Dispos 26:838-847.
7. Court MH, Duan SX, von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, and Mackenzie PI (2001) Interindividual variability in acetaminophen glucuronidation by human liver microsomes: Identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ther 299:998-1006.
8. Fisher MB, Paine MF, Strelevitz TJ, and Wrighton SA (2001) The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metab Rev 33:273-297.
9. Furlan V, Demirdjian S, Bourdon O, Magdalou J, and Taburet A-M (1999) Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers. J Pharmacol Exp Ther 289:1169-1175.
10. Ghosheh O and Hawes EM (2002) N-Glucuronidation of nicotine and cotinine in human: Formation of cotinine glucuronide in liver microsomes and lack of catalysis by ten examined UDP-glucuronosyltransferases. Drug Metab Dispos 30:991-996.
11. Ghosheh O, Vashishtha SC, and Hawes EM (2001) Formation of the quaternary ammoniumlinked glucuronide of nicotine in human liver microsomes: Identification and stereoselectivity in the kinetics. Drug Metab Dispos 29:1525-1528.
12. Green MD, Bishop WP, and Tephly TR (1995) Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. Drug Metab Dispos 23:299-302.
13. Green MD, King CD, Mojarrabi B, Mackenzie PI, and Tephly TR (1998) Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 26:507-512.
14. Green MD and Tephly TR (1996) Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein. Drug Metab Dispos 24:356-363.
15. Hucker HB, Stauffer SC, Balletto AJ, White SD, Zacchei AG, and Arison BH (1978) Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man. Drug Metab Dispos 6:659-672.
16. Inoue K, Yamazaki H, and Shimada T (2000) CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians. Arch Toxicol 73:532-539.
17. King CD, Rios GR, Green MD, and Tephly TR (2000) UDP-Glucuronosyltransferases. Curr Drug Metab 1:143-161.
18. Lehman JP, Fenselau C, and dePaulo JR (1983) Quaternary ammonium-linked glucuronides of amitriptyline, imipramine, and chlorpromazine. Drug Metab Dispos 11:221-225.
19. Li C, Chauret N, Trimble LA, Nicoll-Griffith DA, Silva JM, MacDonald D, Perrier H, Yergey JA, Parton T, Alexander RP, and Warrellow GJ (2001) Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: Leading to structural optimization. Drug Metab Dispos 29:232-241.
20. Liston HL, Markowitz JS, and DeVane CL (2001) Drug glucuronidation in clinical psychopharmacology. J Clin Psychopharmacol 21:500-515.
21. Lowry DH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
22. McGurk KA, Brierley CH, and Burchell B (1998) Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochem Pharmacol 55:1005-1012.
23. Nakajima M, Kwon J-T, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, Yamazaki H, Yamamoto T, Kuroiwa Y, and Yokoi T (2001) Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin Pharmacol Ther 69:72-78.
24. Oscarson M (2001) Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: Implications for interindividual differences in nicotine metabolism. Drug Metab Dispos 29:91-95.
25. Raunio H, Rautio A, Gullstén H, and Pelkonen O (2001) Polymorphisms of CYP2A6 and its practical consequences. Br J Clin Pharmacol 52:357-363.
26. Remmel RP and Sinz MW (1991) A quaternary ammonium glucuronide is the major metabolite of lamotrigine in guinea pigs, in vitro and in vivo studies. Drug Metab Dispos 19:630-636.
27. Seaton MJ, Kyerematen GA, and Vesell ES (1993b) Rates of excretion of cotinine, nicotine glucuronide, and 3-hydroxycotinine glucuronide in rat bile. Drug Metab Dispos 21:927-932.
28. Seaton MJ, Vesell ES, Luo H, and Hawes EM (1993a) Identification of radiolabeled metabolites of nicotine in rat bile, synthesis of S-(-)-nicotine N-glucuronide, and direct separation of nicotine-derived conjugates using high-performance liquid chromatography. J Chromatogr 621:49-53.
29. Shipkova M, Strassburg CP, Braun F, Streit F, Gröne H-J, Armstrong VW, Tukey RH, Oellerich M, and Wieland E (2001) Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes. Br J Clin Pharmacol 132:1027-1034.
30. Soars MG, Riley RJ, and Burchell B (2001a) Evaluation of the marmoset as a model species for drug glucuronidation. Xenobiotica 31:849-860.
31. Soars MG, Riley RJ, Findlay KAB, Coffey MJ, and Burchell B (2001b) Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney. Drug Metab Dispos 29:121-126.
32. Strassburg CP, Kneip S, Topp J, Obermayer-Straub P, Barut A, Tukey RH, and Manns MP (2000) Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine. J Biol Chem 275:36164-36171.
33. Strassburg CP, Nguyen N, Manns MP, and Tukey RH (1999) UDP-glucuronosyltransferase activity in human liver and colon. Gastroenterology 116:149-160.
34. Tsai M-C and Gorrod JW (1999) Evidence for the biosynthesis of a glucuronide conjugate of (S)-(-)-nicotine, but not (S)-(-)-cotinine or (±)-trans-3′-hydroxycotinine by marmoset hepatic microsomes. Drug Metab Drug Interact 15:223-237.
35. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: Metabolism, expression and disease. Annu Rev Pharmacol Toxicol 40:581-616.
36. Tukey RH and Strassburg CP (2001) Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol Pharmacol 59:405-414.
37. Tyndale RF and Sellers EM (2001) Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. Drug Metab Dispos 29:548-552.
38. Vashishtha SC, Hawes EM, McCann DJ, Ghosheh O, and Hogg L (2002) Quaternary ammonium-linked glucuronidation of I-substituted imidazoles by liver microsomes: Interspecies differences and structure-metabolism relationships. Drug Metab Dispos 30:1070-1076.